<DOC>
	<DOCNO>NCT00171600</DOCNO>
	<brief_summary>Title : Antialbuminuric effect valsartan , lisinopril valsartan versus lisinopril non-diabetic diabetic renal disease : randomize ( 3:3:1 ) , open label , parallel group , 20 week follow-up . Objective : To evaluate antialbuminuric effect high dos valsartan vs lisinopril v combo treatment non-diabetic diabetic patient . Hypothesis : Combo treatment reduces microalbuminuria albumin/creatinine ratio monotherapies.. Design : Multicentric , randomize , open label , parallel group , active control . Dose / regimen : Valsartan 320 v Lisinopril 40 v Valsartan/lisinopril 160/20 Primary Endpoint : Antialbuminuric effect valsartan 320 mg , lisinopril valsartan versus lisinopril 40 mg non-diabetic diabetic renal disease follow 5 month follow-up . Description % change albuminuria baseline 20 week . Secondary Endpoint : To investigate effect 5 month treatment valsartan , lisinopril valsartan versus lisinopril GFR ( Cl creatinine ) , also investigate effect 5 month treatment valsartan , lisinopril valsartan plus lisinopril blood pressure effect leave ventricular mass index use electrocardiogram Cornell-Sokolow method .</brief_summary>
	<brief_title>Antialbuminuric Effects Valsartan Lisinopril</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Male female outpatient age 4075 year , Chronic nephropathy , define serum creatinine concentration &gt; 1.3 mg/dL calculate glomerular filtration rate &gt; 30 mL/min/1.73 m2 . Persistent albuminuria , define urinary albumin excretion exceed 20 mg/ 24 h &gt; 1000 mg/ 24h . ( minimum three month ) . Hypertensive patient adequately control without treatment ( control : &lt; 130/80 mmHg ) . Written inform consent participate study prior study procedure . Immediate need renal replacement therapy . Treatment resistant oedema nephrotic syndrome . Need treatment corticosteroid , nonsteroidal antiinflammatory drug , immunosuppressive drug . Albuminuria great 1000mg /24h less 20mg/24h . Total cholesterol &lt; 135mg/dl need statin treatment . Renovascular hypertension Malignant hypertension MI , cerebrovascular accident within last year , severe peripheral vascular disease , CHF , chronic hepatic disease . Angiotensin convert enzyme inhibitor angiotensin II receptor blocker within one month prior randomization . A serum creatinine concentration &gt; 265 umol/L</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>valsartan</keyword>
	<keyword>lisinopril</keyword>
	<keyword>albuminuria</keyword>
	<keyword>diabetic nephropathy</keyword>
</DOC>